Harbor Investment Advisory LLC has a $41,000 stake in InMode Ltd. (NASDAQ:INMD)


Harbor Investment Advisory LLC reduced its stake in shares of InMode Ltd. (NASDAQ:INMD – Get Rating ) by 69.4% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 1,100 shares of the healthcare company’s stock after selling 2,500 shares during the period. Harbor Investment Advisory LLC’s holdings in InMode were worth $41,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Baillie Gifford & Co. grew its position in shares of InMode by 70.8% in the 4th quarter. Baillie Gifford & Co. now owns 526 shares of the healthcare company’s stock valued at $37,000 after purchasing an additional 218 shares during the period. Knuff & Co LLC boosted its position in shares of InMode by 100.0% in the 4th quarter. Knuff & Co LLC now owns 500 shares of the healthcare company’s stock valued at $35,000 after buying an additional 250 shares during the period. Core Wealth Advisors Inc. increased its position in shares of InMode by 100.0% during the 4th quarter. Core Wealth Advisors Inc. now owns 500 shares of the healthcare company’s stock valued at $35,000 after purchasing an additional 250 shares during the period. Signaturefd LLC boosted its position in shares of InMode by 31.9% during the 4th quarter. Signaturefd LLC now owns 1,124 shares of the healthcare company’s stock valued at $79,000 after buying an additional 272 shares during the period. Finally, North Star Investment Management Corp. increased its position in shares of InMode by 100.0% during the 4th quarter. North Star Investment Management Corp. now owns 600 shares of the healthcare company’s stock valued at $42,000 after purchasing an additional 300 shares during the period. 53.58% of the shares are owned by institutional investors.

INMD opened at $22.51 on Monday. The company has a market cap of $1.87 billion, a price-to-earnings ratio of 11.46 and a beta of 2.13. The firm’s fifty day moving average is $24.21 and its two hundred day moving average is $38.13. InMode Ltd. has a 1-year low of $20.60 and a 1-year high of $99.27.

InMode (NASDAQ:INMD – Get Rating ) last posted its quarterly earnings data on Monday, May 2nd. The healthcare company reported $0.36 earnings per share (EPS) for the quarter. The firm had revenue of $85.90 million for the quarter, compared to the consensus estimate of $83.45 million. InMode had a net margin of 44.79% and a return on equity of 43.98%. The business’s revenue for the quarter was up 31.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.69 EPS.

Several analysts have recently issued reports on INMD shares. Canaccord Genuity Group cut their target price on shares of InMode from $50.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday. Needham & Company LLC reissued a “buy” rating and issued a $82.00 target price on shares of InMode in a research report on Monday, April 18th. TheStreet downgraded InMode from a “c-” rating to a “d+” rating in a research report on Tuesday, May 17th. Robert W. Baird cut their target price on shares of InMode from $82.00 to $57.00 in a research report on Tuesday, May 3rd. Finally, Canaccord Genuity Group cut their target price on shares of InMode from $50.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday. Six investment analysts have rated the stock with a buy rating. The company has a consensus rating of “Buy” and an average price target of $67.33, based on data from MarketBeat.

InMode profile (Get Rating)

InMode Ltd. designs, develops, manufactures and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency-assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for a variety of procedures, such as liposuction with simultaneous skin tightening, body and facial contouring, and ablative skin rejuvenation procedures, as well as for use in women’s health conditions and procedures.

Featured stories

Want to see what other hedge funds hold INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider deals for InMode Ltd. (NASDAQ:INMD – Get Rating).

Institutional Ownership by Quarter for InMode (NASDAQ:INMD)



Get InMode news and ratings every day – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for InMode and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Comment

Your email address will not be published.